Project Grant R01NS133045
Award Date
8/15/24
Completion Date
6/30/29
Dollars Obligated
$558K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $148,568 to investigate the mechanisms of dopamine transmission and its role in reward-related behaviors. The award period runs from January 1, 2025 to July 31, 2027. The funded research aims to advance the mechanistic understanding of how dopamine signaling occurs at the subcellular level, given limitations in prior methodologies. The...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to uncover the neural circuit mechanisms that generate dopamine neuron activity and dopamine reward prediction error (RPE) signals. The $656,073 award to President and Fellows of Harvard College will support three key research objectives: Examining the roles of glutamate and GABA inputs to dopamine neurons in generating dopamine RPE...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $529,878 to Boston Children's Hospital to conduct research on the molecular mechanisms underlying dopamine receptor desensitization and its role in motivational control. The 5-year project aims to establish a new platform for rapidly identifying and understanding the...
This federal Project Grant award, totaling $481,049.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) grant program. The project, titled "Substantia Nigra Circuits in Instrumental Action," aims to characterize how the substantia nigra pars reticulata (SNR) regulates divergent nigrostriatal dopamine pathways and determine the roles of specific...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $162,672 to the University of California, Los Angeles (UCLA) to conduct research on the role of dopamine projections to the amygdala in goal-directed and habit learning. The award period runs from August 1, 2024 to March 31, 2028. The key objectives are to use in vivo fiber photometry imaging and optogenetic manipulation techniques to...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $417,861.00 to investigate the neural mechanisms underlying individual differences in reward-based learning strategies and their relationship to addiction-like behaviors. The 5-year research project, conducted by the Regents of the University of Minnesota, will focus on the role of dopamine signaling in the basolateral amygdala in mediating the...
This $774,632 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to investigate the neural basis of dopamine-driven deficits in cognition and perception. The primary objectives are to use in vivo imaging to determine how excess dopamine alters the activity of D1 and D2 dopamine receptor-expressing spiny projection neurons in the dorsal striatum, and how selectively activating substantia...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will provide $606,548 to the University of Pittsburgh to develop a new "mesoscopic electrophysiology" recording system for non-human primates. The goal is to create a system that combines the large field of view and spatial resolution of fMRI with the high temporal...
This federal Project Grant award of $1,785,632.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding supports research at the University of Pittsburgh to elucidate the cellular and behavioral function of astrocytic dopamine signaling in the nucleus accumbens region of the brain. The key objectives are to characterize the role of astrocytic dopamine D1 receptors in the induction and expression of heterosynaptic...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $173,140 to The Regents of the University of California, San Francisco (UCSF) to elucidate the role of neural activity in the degeneration of midbrain dopamine neurons, which is a key pathological process in Parkinson's disease. The project aims to use novel mouse models to...